Tocilizumab was one of the first drugs to be considered against Sars-CoV-2 disease (beraking latest news Salute) – Tocilizumab was one of the first drugs to be considered at the start of the pandemic as a potential treatment for Covid-19, for via “its ability to block the action of interleukin-6, a substance produced by the immune system in response to inflammation”, an element that “plays an important role in Covid-19 disease”.
Even in Italy this path was already attempted in March 2020 (the first Covid cases treated off label in Naples) and a large study to evaluate the drug had been launched shortly. Now the EMA will consider whether to authorize the extension of use of this anti-arthritis drug authorized for the first time in the EU in 2009.
The CHMP opinion, together with any requirements for further studies and safety monitoring, will be forwarded – the EMA recalls in a note – to the European Commission, which will issue a final legally binding decision applicable in all EU member states.
below) // the var will be used by PaywallMeter to target the event on the correct pixel settings_testata.fbq_swg_promo = ‘3250029561771476’; fbq (‘init’, ‘3250029561771476’); fbq (‘track’, ‘PageView’);